Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yiyang Huoluo Decoction in Senile Atherosclerosis and Coronary Heart Disease
NCT07493603Phase 2Recruiting
- Sponsor
- Xia Liang
- Start
- Jan 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Yiyang Huoluo Decoction in coronary heart disease (CHD), atherosclerosis, stable angina pectoris, sponsored by Xia Liang. Started Jan 2026; status: recruiting.
02
Drugs
Yiyang Huoluo Decoction
03
Conditions
coronary heart disease (CHD)atherosclerosisstable angina pectoris
Beyond the preview
Go deeper on NCT07493603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07493603.